AUA: Upper Tract Urothelial Carcinoma (2023): Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
Line 87: | Line 87: | ||
**#Other malignancies | **#Other malignancies | ||
*'''<span style="color:#ff0000">Assessment of renal function</span>''' | *'''<span style="color:#ff0000">Assessment of renal function</span>''' | ||
** | **Can help with patient counseling, strategizing treatment sequence (operative approach and administration of systemic therapy), and determination of downstream risks of CKD and potential dialysis. | ||
***Recommended tests include serum creatinine to calculate an eGFR | |||
****For more refined evaluation, split function testing such as with differential renal scan or CT volumetric studies may be considered. | |||
***The two formulas for monitoring eGFR commonly reported in the contemporary literature at this time are the [https://www.mdcalc.com/calc/76/mdrd-gfr-equation Modification of Diet in Renal Disease] and [https://www.mdcalc.com/calc/3939/ckd-epi-equations-glomerular-filtration-rate-gfr CKD – Epidemiology Collaboration (CKD-EPI)] equations. | ***The two formulas for monitoring eGFR commonly reported in the contemporary literature at this time are the [https://www.mdcalc.com/calc/76/mdrd-gfr-equation Modification of Diet in Renal Disease] and [https://www.mdcalc.com/calc/3939/ckd-epi-equations-glomerular-filtration-rate-gfr CKD – Epidemiology Collaboration (CKD-EPI)] equations. | ||
Line 227: | Line 229: | ||
***'''Toxicities associated with surgical treatment''' | ***'''Toxicities associated with surgical treatment''' | ||
****'''Risk of post-NU CKD or dialysis.''' | ****'''Risk of post-NU CKD or dialysis.''' | ||
***** | ******* | ||
** | |||
*******'''Predictive factors for post-operative development of CKD or progression of pre-existing CKD include (8):''' | *******'''Predictive factors for post-operative development of CKD or progression of pre-existing CKD include (8):''' | ||
*******#'''Older age''' | *******#'''Older age''' |